Literature DB >> 8883568

Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders.

M Albus1, W Hubmann, C Wahlheim, N Sobizack, U Franz, F Mohr.   

Abstract

Patients with first-episode (FE) schizophrenia (n = 27), unipolar depression (n = 10) and bipolar disorder (n = 17) and age- and gender-matched healthy control subjects (n = 27) were administered a battery of neuropsychological (NP) tests. FE schizophrenics performed significantly less well than patients with affective disorders in the area of visual motor processing and attention. Affective disorder patients without psychotic features did not perform significantly differently to controls. However, affective disorder patients with psychotic features performed as poorly as schizophrenics, with the most pronounced impairment in the area of visual motor processing and attention. Our data tentatively suggest the existence of a dichotomy in neuropsychological impairment, with psychotic patients showing similar neuropsychological deficits, while non-psychotic affective patients perform comparably to controls.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883568     DOI: 10.1111/j.1600-0447.1996.tb09830.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  36 in total

1.  Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.

Authors:  Aina Holmén; Monica Juuhl-Langseth; Rune Thormodsen; Ingrid Melle; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

2.  Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study.

Authors:  Isabelle E Bauer; Austin Ouyang; Benson Mwangi; Marsal Sanches; Giovana B Zunta-Soares; Richard S E Keefe; Hao Huang; Jair C Soares
Journal:  J Psychiatr Res       Date:  2015-02-07       Impact factor: 4.791

3.  Should cognitive impairment be included in the diagnostic criteria for schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 4.  Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.

Authors:  Taiane Cardoso; Isabelle E Bauer; Thomas D Meyer; Flavio Kapczinski; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

5.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

6.  Cognitive impairment in affective psychoses: a meta-analysis.

Authors:  Emre Bora; Murat Yücel; Christos Pantelis
Journal:  Schizophr Bull       Date:  2009-09-18       Impact factor: 9.306

7.  Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.

Authors:  Boaz Levy; Roger D Weiss
Journal:  J Clin Psychiatry       Date:  2009-11-17       Impact factor: 4.384

8.  Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study.

Authors:  Boaz Levy; Anna Marie Medina; Roger D Weiss
Journal:  Compr Psychiatry       Date:  2013-01-26       Impact factor: 3.735

9.  A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

Authors:  S Kristian Hill; James L Reilly; Margret S H Harris; Cherise Rosen; Robert W Marvin; Ovidio Deleon; John A Sweeney
Journal:  Schizophr Res       Date:  2009-05-17       Impact factor: 4.939

10.  Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis.

Authors:  Taís M Minatogawa-Chang; Maristela S Schaufelberger; Adriana M Ayres; Fábio L S Duran; Elisa K Gutt; Robin M Murray; Teresa M Rushe; Philip K McGuire; Paulo R Menezes; Marcia Scazufca; Geraldo F Busatto
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.